Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 1
2011 2
2012 2
2013 6
2014 7
2015 17
2016 16
2017 14
2018 12
2019 14
2020 12
2021 5
2022 11
2023 13
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean yong hyun hang (1 results)?
Two Phase 3 Trials of Baricitinib for Alopecia Areata.
King B, Ohyama M, Kwon O, Zlotogorski A, Ko J, Mesinkovska NA, Hordinsky M, Dutronc Y, Wu WS, McCollam J, Chiasserini C, Yu G, Stanley S, Holzwarth K, DeLozier AM, Sinclair R; BRAVE-AA Investigators. King B, et al. N Engl J Med. 2022 May 5;386(18):1687-1699. doi: 10.1056/NEJMoa2110343. Epub 2022 Mar 26. N Engl J Med. 2022. PMID: 35334197 Clinical Trial.
Necrolytic migratory erythema.
Lee HJ, Jang YH. Lee HJ, et al. Among authors: jang yh. CMAJ. 2019 Mar 11;191(10):E286. doi: 10.1503/cmaj.180913. CMAJ. 2019. PMID: 30858185 Free PMC article. No abstract available.
Bakuchicin attenuates atopic skin inflammation.
Lim JS, Kim JY, Lee S, Choi JK, Kim EN, Choi YA, Jang YH, Jeong GS, Kim SH. Lim JS, et al. Among authors: jang yh. Biomed Pharmacother. 2020 Sep;129:110466. doi: 10.1016/j.biopha.2020.110466. Epub 2020 Jul 1. Biomed Pharmacother. 2020. PMID: 32768955 Free article.
Lack of effect of benralizumab on signs and symptoms of moderate-to-severe atopic dermatitis: Results from the phase 2 randomized, double-blind, placebo-controlled HILLIER trial.
Guttman-Yassky E, Bahadori L, Brooks L, Clark KL, Grindebacke H, Ho CN, Katial R, Pham TH, Walton C, Datto CJ; HILLIER study group†. Guttman-Yassky E, et al. J Eur Acad Dermatol Venereol. 2023 Oct;37(10):e1211-e1214. doi: 10.1111/jdv.19195. Epub 2023 Jun 12. J Eur Acad Dermatol Venereol. 2023. PMID: 37178404 Clinical Trial. No abstract available.
Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation.
Park KD, Kim N, Kang J, Dhakal H, Kim JY, Jang YH, Lee WJ, Lee SJ, Kim SH. Park KD, et al. Among authors: jang yh. Int Immunopharmacol. 2021 Sep;98:107883. doi: 10.1016/j.intimp.2021.107883. Epub 2021 Jun 19. Int Immunopharmacol. 2021. PMID: 34153674
Clinical Investigation on Preadolescent Acne.
Eun DH, Kim JY, Jang YH, Lee SJ, Lee WJ. Eun DH, et al. Among authors: jang yh. Ann Dermatol. 2019 Apr;31(2):249-251. doi: 10.5021/ad.2019.31.2.249. Epub 2019 Feb 28. Ann Dermatol. 2019. PMID: 33911585 Free PMC article. No abstract available.
125 results